Effect of pretreatment with omalizumab on the tolerability of specific immunotherapy in allergic asthma

Adkinson, 1999, Immunotherapy for allergic rhinitis, N Engl J Med, 341, 522, 10.1056/NEJM199908123410710 Lockey, 2001, ARIA: global guidelines and new forms of allergen immunotherapy, J Allergy Clin Immunol, 108, 497, 10.1067/mai.2001.118638 Abramson, 2003, Allergen immunotherapy for asthma (review), Cochrane Database Syst Rev, 4, CD001186 Bernstein, 2004, Twelve-year survey of fatal reactions to allergen injections and skin testing: 1990-2001, J Allergy Clin Immunol, 113, 1129, 10.1016/j.jaci.2004.02.006 MacGlashan, 1997, Down-regulation of Fc(epsilon)RI expression on human basophils during in vivo treatment of atopic patients with anti-IgE antibody, J Immunol, 158, 1438, 10.4049/jimmunol.158.3.1438 Prussin, 2003, Omalizumab treatment downregulates dendritic cell FcepsilonRI expression, J Allergy Clin Immunol, 112, 1147, 10.1016/j.jaci.2003.10.003 Busse, 2001, Omalizumab, anti-IgE recombinant humanized monoclonal antibody, for the treatment of severe allergic asthma, J Allergy Clin Immunol, 108, 184, 10.1067/mai.2001.117880 Solèr, 2001, The anti-IgE antibody omalizumab reduces exacerbations and steroid requirement in allergic asthmatics, Eur Respir J, 18, 254, 10.1183/09031936.01.00092101 Casale, 2006, Omalizumab pretreatment decreases acute reactions after rush immunotherapy for ragweed-induced seasonal allergic rhinitis, J Allergy Clin Immunol, 117, 134, 10.1016/j.jaci.2005.09.036 Kuehr, 2002, Efficacy of combination treatment with anti-IgE plus specific immunotherapy in polysensitized children and adolescents with seasonal allergic rhinitis, J Allergy Clin Immunol, 109, 274, 10.1067/mai.2002.121949 Ewbank, 2003, A double-blind, placebo-controlled immunotherapy dose-response study with standardized cat extract, J Allergy Clin Immunol, 111, 155, 10.1067/mai.2003.41 Walker, 2001, Grass pollen immunotherapy for seasonal rhinitis and asthma: a randomized, controlled trial, J Allergy Clin Immunol, 107, 87, 10.1067/mai.2001.112027 Cox, 2008, Advantages and disadvantages of accelerated immunotherapy schedules, J Allergy Clin Immunol, 122, 432, 10.1016/j.jaci.2008.06.007 Global Initiative for Asthma. GINA report, global strategy for asthma management and prevention. Revised 2006. Available at: http://www.ginasthma.org/. Accessed September 22, 2009. Müller, 1966, Diagnosis and treatment of insect sensitivity, J Asthma Res, 3, 331, 10.3109/02770906609106941 Collett, 2003 Lachin, 2000 Stokes, 2000 Freedman, 1982, Tables of the number of patients required in clinical trials using the logrank test, Stat Med, 1, 121, 10.1002/sim.4780010204 Nielsen, 1996, Antihistamine premedication in specific cluster immunotherapy: a double-blind, placebo-controlled study, J Allergy Clin Immunol, 97, 1207, 10.1016/S0091-6749(96)70186-0 Kamin W, Kopp MV, Erdnuess F, Schauer U, Zielen S, Wahn U. Safety of anti-IgE treatment with omalizumab in children with seasonal allergic rhinitis undergoing specific immunotherapy simultaneously. Pediatr Allergy Immunol. In press 2009. Rolinck-Werninghaus, 2004, The co-seasonal application of anti-IgE after preseasonal specific immunotherapy decreases ocular and nasal symptom scores and rescue medication use in grass pollen allergic children, Allergy, 59, 973, 10.1111/j.1398-9995.2004.00552.x